Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1994 Jul;72(1):16–22. doi: 10.1136/hrt.72.1.16

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

A M Choy 1, D Darbar 1, C C Lang 1, T H Pringle 1, G P McNeill 1, N S Kennedy 1, A D Struthers 1
PMCID: PMC1025420  PMID: 7741839

Abstract

OBJECTIVE--The SAVE study showed that captopril improves mortality in patients with left ventricular dysfunction after myocardial infarction and that this benefit occurred even in patients with no clinically overt heart failure. On the basis of this, it seems important to identify correctly which patients have left ventricular dysfunction after a myocardial infarction. The objective was to compare various methods of identifying patients with left ventricular dysfunction (left ventricular ejection fraction, LVEF, < or = 40%) after acute myocardial infarction. The methods compared were echocardiography (quantitative and qualitative visual assessment), clinical evaluation (subjective assessment and three clinical score methods), and measurement of plasma concentrations of cardiac natriuretic peptide hormones (atrial and brain natriuretic peptides, ANP and BNP). DESIGN--Cross sectional study of left ventricular function in patients two to eight days after acute myocardial infarction. SETTING--Coronary care unit of a teaching hospital. PATIENTS--75 survivors of a recent myocardial infarction aged 40 to 88 with no history of cardiac failure and without cardiogenic shock at the time of entry to the study. MAIN OUTCOME MEASURES--Sensitivities and specificities of the various methods of detecting left ventricular dysfunction were calculated by comparing them with a cross sectional echocardiographic algorithm for LVEF. RESULTS--Clinical impression was poor at identifying LVEF < 40% (sensitivity 46%). Clinical scoring improved this figure somewhat (modified Peel index sensitivity 64%). Qualitative visual assessment echocardiography was a more sensitive method (sensitivity 82%) for detecting LVEF < 40%. Plasma BNP concentration was also a sensitive measure for detecting left ventricular dysfunction (sensitivity 84%) but plasma ANP concentration was much poorer (sensitivity 64%). CONCLUSION--Left ventricular dysfunction is easily and reliably detected by echocardiographic measurement of LVEF and also by a quick qualitative echocardiographic assessment but is likely to be missed by clinical assessment alone. High concentrations of plasma BNP maybe another useful indicator of left ventricular dysfunction, particularly in hospitals where not all patients can be screened by echocardiography or radionuclide ventriculography after myocardial infarction.

Full text

PDF
16

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohn J. N. The prevention of heart failure--a new agenda. N Engl J Med. 1992 Sep 3;327(10):725–727. doi: 10.1056/NEJM199209033271010. [DOI] [PubMed] [Google Scholar]
  2. DODGE H. T., SANDLER H., BALLEW D. W., LORD J. D., Jr The use of biplane angiocardigraphy for the measurement of left ventricular volume in man. Am Heart J. 1960 Nov;60:762–776. doi: 10.1016/0002-8703(60)90359-8. [DOI] [PubMed] [Google Scholar]
  3. Eagle K. A., Quertermous T., Singer D. E., Mulley A. G., Reder V. A., Boucher C. A., Strauss H. W., Thibault G. E. Left ventricular ejection fraction. Physician estimates compared with gated blood pool scan measurements. Arch Intern Med. 1988 Apr;148(4):882–885. [PubMed] [Google Scholar]
  4. Folland E. D., Parisi A. F., Moynihan P. F., Jones D. R., Feldman C. L., Tow D. E. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation. 1979 Oct;60(4):760–766. doi: 10.1161/01.cir.60.4.760. [DOI] [PubMed] [Google Scholar]
  5. Fontana F., Bernardi P., Spagnolo N., Capelli M. Plasma atrial natriuretic factor in patients with acute myocardial infarction. Eur Heart J. 1990 Sep;11(9):779–787. doi: 10.1093/oxfordjournals.eurheartj.a059797. [DOI] [PubMed] [Google Scholar]
  6. Francis G. S., Benedict C., Johnstone D. E., Kirlin P. C., Nicklas J., Liang C. S., Kubo S. H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990 Nov;82(5):1724–1729. doi: 10.1161/01.cir.82.5.1724. [DOI] [PubMed] [Google Scholar]
  7. Gottlieb S. S., Kukin M. L., Ahern D., Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. doi: 10.1016/0735-1097(89)90344-6. [DOI] [PubMed] [Google Scholar]
  8. Gutierrez-Marcos F. M., Fernandez-Cruz A., Gutkowska J., Herrero C., Blesa A., Estrada V., Loscos C., López-Novoa J. M. Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure. Eur Heart J. 1991 Apr;12(4):503–507. doi: 10.1093/oxfordjournals.eurheartj.a059930. [DOI] [PubMed] [Google Scholar]
  9. Kennedy J. W., Trenholme S. E., Kasser I. S. Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods. Am Heart J. 1970 Sep;80(3):343–352. doi: 10.1016/0002-8703(70)90099-2. [DOI] [PubMed] [Google Scholar]
  10. Killip T., 3rd, Kimball J. T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967 Oct;20(4):457–464. doi: 10.1016/0002-9149(67)90023-9. [DOI] [PubMed] [Google Scholar]
  11. Lang C. C., Choy A. M., Henderson I. S., Coutie W. J., Struthers A. D. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci (Lond) 1992 Feb;82(2):127–131. doi: 10.1042/cs0820127. [DOI] [PubMed] [Google Scholar]
  12. Lang C. C., Choy A. M., Struthers A. D. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci (Lond) 1992 Nov;83(5):519–527. doi: 10.1042/cs0830519. [DOI] [PubMed] [Google Scholar]
  13. Lang C. C., Coutie W. J., Khong T. K., Choy A. M., Struthers A. D. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens. 1991 Sep;9(9):779–782. doi: 10.1097/00004872-199109000-00002. [DOI] [PubMed] [Google Scholar]
  14. Lang C. C., Coutie W. J., Struthers A. D., Dhillon D. P., Winter J. H., Lipworth B. J. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992 Nov;83(5):529–533. doi: 10.1042/cs0830529. [DOI] [PubMed] [Google Scholar]
  15. Lerman A., Gibbons R. J., Rodeheffer R. J., Bailey K. R., McKinley L. J., Heublein D. M., Burnett J. C., Jr Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993 May 1;341(8853):1105–1109. doi: 10.1016/0140-6736(93)93125-k. [DOI] [PubMed] [Google Scholar]
  16. Marshall R. C., Berger H. J., Costin J. C., Freedman G. S., Wolberg J., Cohen L. S., Gottschalk A., Zaret B. L. Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion. Circulation. 1977 Nov;56(5):820–829. doi: 10.1161/01.cir.56.5.820. [DOI] [PubMed] [Google Scholar]
  17. Motwani J. G., McAlpine H., Kennedy N., Struthers A. D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993 May 1;341(8853):1109–1113. doi: 10.1016/0140-6736(93)93126-l. [DOI] [PubMed] [Google Scholar]
  18. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., Shirakami G., Jougasaki M., Obata K., Yasue H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991 Apr;87(4):1402–1412. doi: 10.1172/JCI115146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mukoyama M., Nakao K., Obata K., Jougasaki M., Yoshimura M., Morita E., Hosoda K., Suga S., Ogawa Y., Yasue H. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun. 1991 Oct 15;180(1):431–436. doi: 10.1016/s0006-291x(05)81311-7. [DOI] [PubMed] [Google Scholar]
  20. Ngo L., Vesely D. L., Bissett J. K., Murphy M. L., Dinh H., Seth R., Sallman A. L., Rico D. M., Winters C. J., Wyeth R. P. Acute and sustained release of atrial natriuretic factor with acute myocardial infarction. Am Heart J. 1989 Nov;118(5 Pt 1):893–900. doi: 10.1016/0002-8703(89)90220-2. [DOI] [PubMed] [Google Scholar]
  21. Norris R. M., Caughey D. E., Deeming L. W., Mercer C. J., Scott P. J. Coronary prognostic index for predicting survival after recovery from acute myocardial infarction. Lancet. 1970 Sep 5;2(7671):485–487. doi: 10.1016/s0140-6736(70)90110-8. [DOI] [PubMed] [Google Scholar]
  22. Peel A. A., Semple T., Wang I., Lancaster W. M., Dall J. L. A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION. Br Heart J. 1962 Nov;24(6):745–760. doi: 10.1136/hrt.24.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  24. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  25. Pfeffer M. A., Lamas G. A., Vaughan D. E., Parisi A. F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988 Jul 14;319(2):80–86. doi: 10.1056/NEJM198807143190204. [DOI] [PubMed] [Google Scholar]
  26. Reduto L. A., Berger H. J., Cohen L. S., Gottschalk A., Zaret B. L. Sequential radionuclide assessment of left and right ventricular performance after acute transmural myocardial infarction. Ann Intern Med. 1978 Oct;89(4):441–447. doi: 10.7326/0003-4819-89-4-441. [DOI] [PubMed] [Google Scholar]
  27. Richards A. M., Tonolo G., McIntyre G. D., Leckie B. J., Robertson J. I. Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens. 1987 Apr;5(2):227–236. doi: 10.1097/00004872-198704000-00015. [DOI] [PubMed] [Google Scholar]
  28. Rigo P., Murray M., Strauss H. W., Taylor D., Kelly D., Weisfeldt M., Pitt B. Left ventricular function in acute myocardial infarction evaluation by gated scintiphotography. Circulation. 1974 Oct;50(4):678–684. doi: 10.1161/01.cir.50.4.678. [DOI] [PubMed] [Google Scholar]
  29. Sahasakul Y., Chaithiraphan S., Panchavinnin P., Jootar P., Thongtang V., Srivanasont N., Charoenchob N., Kangkagate C. Multivariate analysis in the prediction of death in hospital after acute myocardial infarction. Br Heart J. 1990 Sep;64(3):182–185. doi: 10.1136/hrt.64.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sanford C. F., Corbett J., Nicod P., Curry G. L., Lewis S. E., Dehmer G. J., Anderson A., Moses B., Willerson J. T. Value of radionuclide ventriculography in the immediate characterization of patients with acute myocardial infarction. Am J Cardiol. 1982 Mar;49(4):637–644. doi: 10.1016/0002-9149(82)91940-3. [DOI] [PubMed] [Google Scholar]
  31. Schelbert H. R., Henning H., Ashburn W. L., Verba J. W., Karliner J. S., O'Rourke R. A. Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. Am J Cardiol. 1976 Oct;38(4):407–415. doi: 10.1016/0002-9149(76)90455-0. [DOI] [PubMed] [Google Scholar]
  32. Schelbert H. R., Verba J. W., Johnson A. D., Brock G. W., Alazraki N. P., Rose F. J., Ashburn W. L. Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. Circulation. 1975 May;51(5):902–909. doi: 10.1161/01.cir.51.5.902. [DOI] [PubMed] [Google Scholar]
  33. Schiller N. B., Shah P. M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358–367. doi: 10.1016/s0894-7317(89)80014-8. [DOI] [PubMed] [Google Scholar]
  34. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  35. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]
  36. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  37. Svanegaard J., Angelo-Nielsen K., Pindborg T. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J. 1992 Jul;68(1):38–42. doi: 10.1136/hrt.68.7.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  39. Tan A. C., van Loenhout T. T., Lamfers E. J., Hooghoudt T. E., Kloppenborg P. W., Benraad T. J. Atrial natriuretic peptide after myocardial infarction. Am Heart J. 1989 Sep;118(3):490–494. doi: 10.1016/0002-8703(89)90262-7. [DOI] [PubMed] [Google Scholar]
  40. Vannan M. K., Taylor D. J., Webb-Peploe M. M., Konstam M. A. ACE inhibitors after myocardial infarction. BMJ. 1993 Feb 27;306(6877):531–532. doi: 10.1136/bmj.306.6877.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. White H. D., Norris R. M., Brown M. A., Brandt P. W., Whitlock R. M., Wild C. J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76(1):44–51. doi: 10.1161/01.cir.76.1.44. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES